Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiomodulatory Effects of Gender-Affirming Hormone Therapy

NCT07128771 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT07128771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07128771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
Lead sponsor
University Hospital, Akershus
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 5, 2025
Completion date
October 31, 2030
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease (cvd) risk factors, gender incongruence